ScholarX: Browsing ScholarWorks

Browsing by Planchard, DavidAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 7 of 7

SCIESCOPUS

A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer

Planchard, David; Wolf, Jürgen; Solomon, Benjamin; Sebastian, Martin; Wermke, Martin; Heist, Rebecca S.; Sun, Jong-Mu; Min Kim, Tae; Reguart, Noemi; Sanmamed, Miguel F., et al.

ArticleIssue Date2024CitationLung Cancer, v.197PublisherElsevier Ireland Ltd

SCIESCOPUS

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations Results From the Phase II TROPION-Lung05 Study

Sands, Jacob; Ahn, Myung-Ju; Lisberg, Aaron; Cho, Byoung Chul; Blumenschein, George; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi; Yoh, Kiyotaka; Heist, Rebecca, et al.

ArticleIssue Date2025CitationJournal of Clinical Oncology, v.43, no.10PublisherLippincott Williams and Wilkins

SCIESCOPUS

Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05

Lisberg, Aaron; Ahn, Myung-Ju; Kitazono, Satoru; Cho, Byoung Chul; Blumenschein, George R.; Shum, Elaine; Pons-Tostivint, Elvire; Goto, Yasushi; Yoh, Kiyotaka; Paz-Ares, Luis G., et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

Camidge, D. Ross; Bar, Jair; Horinouchi, Hidehito; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan; Ciuleanu, Tudor; Daaboul, Nathalie; Liu, Chunling, et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.42, no.25PublisherLippincott Williams and Wilkins

SCIESCOPUS

Trastuzumab deruxtecan (T-DXd) in patients with <i>HER2</i>-mutant metastatic non-small cell lung cancer (mNSCLC): Final analysis results of DESTINY-Lung02.

Janne, Pasi A.; Goto, Yasushi; Kubo, Toshio; Ninomiya, Kiichiro; Kim, Sang-We; Planchard, David; Ahn, Myung-Ju; Smit, Egbert F.; De langen, Adrianus Johannes; Perol, Maurice, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results from the Randomized, Phase II DESTINY-Lung02 Trial open access

Goto, Koichi; Goto, Yasushi; Kubo, Toshio; Ninomiya, Kiichiro; Kim, Sang-We; Planchard, David; Ahn, Myung-Ju; Smit, Egbert F.; de Langen, Adrianus Johannes; Pérol, Maurice, et al.

ArticleIssue Date2023CitationJournal of Clinical Oncology, v.41, no.31, pp 4852 - 4863PublisherLippincott Williams and Wilkins

SCIESCOPUS

TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

Atmaca, Akin; Paz-Ares, Luis; Ahn, Myung-Ju; Lisberg, Aaron; Kitazono, Satoru; Cho, Byoung Chul; Blumenschein, George, Jr.; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi, et al.

ArticleIssue Date2024CitationONCOLOGY RESEARCH AND TREATMENT, v.47, pp 127 - 127PublisherKARGER

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Planchard, DavidAuthor

BROWSE